Stock SIGHT GENSIGHT BIOLOGICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus GenSight Biologics S.A.

Equities

SIGHT

FR0013183985

Real-time Euronext Paris
Other stock markets
 03:44:35 2024-04-26 am EDT 		5-day change 1st Jan Change
0.414 EUR -0.96% Intraday chart for GenSight Biologics S.A. +0.98% -10.00%
Apr. 05 GenSight: financial visibility assured until the end of April CF
Mar. 25 GenSight: share price falls, limited financial visibility CF

Evolution of the average Target Price on GenSight Biologics S.A.

Price target over the last 5 years

History of analyst recommendation changes

3cf9e91.Bg_6-dz3Bac5gt_dqB1o45GVEMEC4KVUZPZnEge4kM8.UUGcgeq_bNda9u3l2E0NtafxWJFut8g9VrkBY0P6opBUTcqylcBrxnXbvA~9ab03eb23b143063335d54351963d90a

Analyst Recommendations on GenSight Biologics S.A.

GENSIGHT : Degroof Petercam initiates buy coverage CF
GENSIGHT BIOLOGICS : Oddo maintains its recommendation despite delays CF
GENSIGHT : Oddo confirms its recommendation on the stock CF
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
0.418 EUR
Average target price
0.4 EUR
Spread / Average Target
-4.31%
High Price Target
0.4 EUR
Spread / Highest target
-4.31%
Low Price Target
0.4 EUR
Spread / Lowest Target
-4.31%

Consensus detail

Consensus revision (last 18 months)

Ratings for GenSight Biologics S.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SIGHT Stock
  4. Consensus GenSight Biologics S.A.